Finally, hope for a young patient with CGD
September 14, 2016
At 16, Brenden was so sick that he started planning his funeral, Harvard Gazette reports. Today, Brenden, who has a rare immune disorder called chronic granulomatous disease (CGD), is 23 years old, back working at a golf course and preparing, with cautious optimism, to return to college. What changed? He participated in a gene therapy clinical trial to correct a disease that severely weakens the infection-fighting abilities. “I had been so sick last year, I was willing to do anything not to be that sick anymore,” Brenden tells the Gazette.